Prostate News Archive
21-Nov-2008
Synta tests prostate-cancer therapy (Boston Business Journal)
Synta Pharmaceuticals Corp. treated the first patient in the clinical trial of its proprietary prostate-cancer drug elesclomol. Swan recalls prostate cancer battle (Herald Sun)
TREASURER Wayne Swan has spoken of his own battle with prostate cancer while announcing $7.5 million for a research centre for the disease. Genetic Risk Factors May Tailor Prostate Cancer Screening Approaches (Science Daily)
Five genetic risk markers for prostate cancer may allow physicians to adapt screening approaches for men at high-risk, particularly African-American men, according to new research.
Back to Prostate News Archive